Brain trauma in aged transgenic mice induces regression of established Aβ deposits

Experimental Neurology

Volumn 163, Issue 1, 2000, Pages 244-252

  Nakagawa, Yasushi ^a,c   Reed, Lee ^a   Nakamura, Michio ^b   McIntosh, Tracy K ^b   Smith, Douglas H ^b   Saatman, Kathryn E ^b   Raghupathi, Ramesh ^b   Clemens, James ^d   Saido, Takaomi C ^e   Lee, Virginia M Y ^a   Trojanowski, John Q ^a  

^a Division of Cell Pathology   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c KYUSHU UNIVERSITY   (Japan)

^d ELI LILLY AND COMPANY   (United States)

^e RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

Author keywords

Alzheimer's disease; Amyloid plaques; Brain injury; Head trauma; PDAPP mice

Indexed keywords

PLATELET DERIVED GROWTH FACTOR; PROTEIN PRECURSOR;

ALZHEIMER DISEASE; AMYLOIDOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ATROPHY; BRAIN INJURY; CONTROLLED STUDY; GENE OVEREXPRESSION; GLIOSIS; HIPPOCAMPUS; MOUSE; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; SENILE PLAQUE; TRANSGENIC MOUSE;

EID: 0034068261     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.2000.7375     Document Type: Article

References (76)

1. Arai H., Lee V. M-Y., Otvos L. Jr., Greenberg B., Lowery D. E., Sharma S. K., Schmidt M. L., Trojanowski J. Q. Defined neurofilament, τ, and β-amyloid precursor protein epitopes distinguish Alzheimer from Non-Alzheimer senile plaques. Proc. Natl. Acad. Sci. USA. 87:1990;2249-2253.
2. Arnold S. E., Trojanowski J. Q., Gur R. E., Blackwell P., Han L-Y., Choi C. Absence of neurodegeneration and neural injury in the cerebral cortex in a sample of elderly patients with schizophrenia. Arch. Gen. Psychiatry. 55:1998;225-232.
3. Buxbaum J. D., Christensen J. L., Ruefli A. A., Greengard P., Loring J. F. Expression of APP in brains of transgenic mice containing the entire human APP gene. Biochem. Biophys. Res. Commun. 197:1993;639-645.
4. Chen K. S., Masliah E., Grajeda H., Guido T., Huang J., Khan K., Motter R., Soriano F., Games D. Neurodegenerative Alzheimer-like pathology in PDAPP 717V-F transgenic mice. Prog. Brain Res. 117:1998;327-334.
5. Citron M., Westaway D., Xia W., Carlson G., Diehl T., Levesque G., Johnson-Wood K., Lee M., Seubert P., Davis A., Kholodenko D., Motter R., Sherrington R., Perry B., Yao H., Strome R., Lieberburg I., Rommens J., Kim S., Schenk D., Fraser P., St. George Hyslop P., Selkoe D. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice. Nat. Med. 3:1997;67-72.
6. Clark R. S. B., Chen J., Watkins S. C. V., Kochanek P. M., Chen M., Stetler R. A., Loeffert J. E. W., Graham S. H. Apoptosis suppressor gene bcl-2 expression after traumatic brain injury in rats. J. Neurosci. 17:1997;9172-9182.
7. Colicos M. A., Dash P. K. Apoptotic morphology of dentate gyrus granule cells following experimental cortical impact injury in rats: Possible role in spatial memory deficits. Brain Res. 739:1996;120-131.
8. Conti A. C., Raghupathi R., Trojanowski J. Q., McIntosh T. Experimental brain injury induces regionally distinct apoptosis during the acute and delayed post-traumatic period. J. Neurosci. 18:1998;5663-5672.
9. Cummings B. J., Pike C. J., Shankle R., Cotman C. W. β-Amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's disease. Neurobiol. Aging. 17:1996;921-933.
10. Curz L., Kutnjak-Urbanc B., Buldyrev S. V., Christie R., Gomez-Ilsa T., Havlin S., McNamara M., Stanley H. E., Hyman B. T. Aggregation and disaggregation of senile plaques in Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 94:1997;7612-7616.
11. Dickson D. W. The pathogenesis of senile plaques. J. Neuropathol. Exp. Neurol. 56:1997;321-339.
12. Dickson D. W. Microglia in Alzheimer's disease and transgenic models: How close the fit? Am. J. Pathol. 154:1999;1627-1631.
13. Duff K. C., Eckman C., Zehr C., Yu X., Prada C., Perez-Tur J., Hutton M., Buce L., Harigaya Y., Yager D., Morgan D., Gordon M. N., Holcomb L., Refolu L., Zenk B., Hardy J., Younkin S. Increased amyloid-beta 42(43) in brains of mice expressing mutant presenilin 1. Nature. 383:1996;710-713.
14. Frautschy S. A., Yang F., Irrizarry M., Hyman B., Saido T. C., Hsiao K., Cole G. M. Microglial response to amyloid plaques in APPsw transgenic mice. Am. J. Pathol. 152:1998;307-317.
15. Fung K. M., Lee V. M-Y., Trojanowski J. Q. Dynamics of cell proliferation and cell death during the emergence of primitive neuroectodermal tumors of the immature central nervous system in transgenic mice. Am. J. Pathol. 146:1995;1376-1387.
16. Games D., Adams D., Alessandrini R., Barbour R., Berthelette P., Blackwell C., Carr T., Clemens J., Donaldson T., Gillespie F., Giodo T., Hagopian S., Johnson-Wood K., Khan K., Lee M., Leibowitz P., Liebergurg I., Little S., Masliah E., McConlogue L., Montoya-Zavala M., Muck E. L., Paganini L., Penniman E., Power M., Schenk D., Seubert P., Snyder B., Soriano F., Tan H., Vitale J., Wadsworth S., Wolozin B., Zhao J. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature. 373:1995;523-527.
17. Gavrieli Y., Sherman Y., Ben-Sasson S. A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119:1992;493-501.
18. Giulian D. Microglia and the immune pathology of Alzheimer disease. Am. J. Hum. Genet. 65:1999;13-18.
19. Goedert M., Trojanowski J. Q., Lee V. M-Y. The neurofibrillary pathology of Alzheimer's disease. Prusiner S. B., Rosenberg R. N., Di Mauro S., Barchi R. L. The Molecular and Genetic Basis of Neurological Disease. 1997;613-627 Butterworth Heineman, Boston.
20. Guillery R. W., Herrup K. Quantification without pontification: Choosing a method for counting objects in sectioned tissues. J. Comp. Neurol. 386:1997;2-7.
21. Hsiao K. Understanding the biology and molecular pathogenesis of Alzheimer's Disease in transgenic mice expressing amyloid precursor proteins. Wasco W., Tanzi R. E. Molecular Mechanisms of Dementia. 1997;39-44 Humana Press, Totowa.
22. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F., Cole G. Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science. 274:1996;99-102.
23. Hyman B. T., Marzloff K., Arriagada P. V. The lack of accumulation of senile plaques or amyloid burden in Alzheimer's disease suggests a dynamic balance between amyloid deposition and resolution. J. Neuropathol. Exp. Neurol. 52:1993;594-600.
24. Irizarry M. C., McNamara M., Fedorchak K., Hsiao K., Hyman B. T. APPsw transgenic mice develop age-related Aβ deposits and neuropil abnormalities, but no neuronal loss in CA1. J. Neuropathol. Exp. Neurol. 56:1997;965-973.
25. Irizarry M. C., Soriano F., McNamara M., Page K. J., Shenk D., Games D., Hyman B. T. Aβ deposition is associated with neuropil changes, but not with overt neuronal loss in the PDAPP transgenic mouse. J. Neurosci. 17:1997;7053-7059.
26. Iwatsubo T., A. D. M., Odaka A., Suzuki N., Ihara Y. Amyloid Aβ protein (Aβ) deposition: Aβ42(43) precedes Aβ40 in Down Syndrome. Ann. Neurol. 37:1995;294-299.
27. Iwatsubo T., Odaka A., Suzuki N., Mizusawa H., Nukina N., Ihara Y. Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42(43). Neuron. 13:1994;45-53.
28. Iwatsubo T., Saido T., Mann D. M. A., Lee V. M-Y., Trojanowski J. Q. Full-length Aβ[1-42(43)] as well as amino-terminally modified and truncated Aβ42(43) deposit in diffuse plaques. Am. J. Pathol. 149:1996;1823-1830.
29. Johnson-Wood K., Lee M., Motter R., Hu R., Gordon G., Barbour R., Khan K., Gordon M., Tan H., Games D., Lieberberg I., Schenk D., Seubert P., McConologue L. Amyloid precursor protein processing and Aβ42 deposition in transgenic mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 94:1997;1550-1554.
30. Jordan B. D., Relkin N. R., Ravdin L. D., Jacobs A. R., Bennett A., Gandy S. Apolipoprotein E ε4 allele associated with chronic traumatic brain injury in boxing. JAMA. 278:1997;136-140.
31. Kuida K., Hayadar T. F., Kuan C., Gu Y., Karasuyama H., Su M. S., Rakic P., Flavell R. Reduced apoptosis and cytochrome c-mediated activation in mice lacking caspase-9. Cell. 94:1998;325-337.
32. Lee V. M-Y., Balin B. J., Otvos L. Jr., Trojanowski J. Q. A68: A major subunit of paired helical filaments and derivatized forms of normal tau. Science. 251:1991;675-678.
33. Lee V. M-Y., Page C. D., Wu H-L., Schlaepfer W. W. Monoclonal antibodies to gel-excised glial filament protein and their reactivities with other intermediate filament proteins. J. Neurochem. 42:1984;25-32.
34. Lewen A., Li G. L., Nilsson P., Olsson Y., Hillered L. Traumatic brain injury in rat produces changes of β-amyloid precursor protein immunoreactivity. NeuroReport. 6:1995;357-360.
35. Loring J, Paszty C., Ross A., McIntosh T. K., Murai H., Pierce J. E. S., Trojanowski J. Q., Schramm S. R., Wymore K., Rubin E. M., Peterson K. R., Lee V. M-Y. Rational design of an animal model for Alzheimer's disease: Introduction of multiple human genomic transgenes to reproduce Alzheimer's disease pathology in a rodent. Neurobiol. Aging. 17:1996;173-182.
36. Masliah E., Sisk A., Mallory M., Mucke L., Schenk D., Games D. Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F β-amyloid precursor protein and Alzheimer's disease. J. Neurosci. 16:1996;5795-5811.
37. Maxwell W. L., Povlishock J. T., Graham D. I. A mechanistic analysis of non-disruptive axonal injury: A review. J. Neurotrauma. 14:1997;419-440.
38. Mayeux R., Ottman R., Maestre G., Ngai C., Tang M., Ginsberg H., Chun M., Tycko B., Shelanski M. Synergistic effects of traumatic head injury and apolipoprotein-ε4 in patients with Alzheimer's disease. Neurology. 45:1995;555-557.
39. McIntosh T. K., Saatman K. E., Raghupathi R., Graham D. I., Smith D. H., Lee V. M-Y., Trojanowski J. Q. The molecular and cellular sequelae of experimental traumatic brain injury: Pathogenic mechanisms. Neuropathol. Appl. Neurobiol. 24:1998;251-267.
40. Morrison-Bogorad M., Weiner M. F., Rosenberg R. N., Bigio E., White C. L. III. Alzheimer's Disease. Prusiner S. B., Rosenberg R. N., Di Mauro S., Barchi R. L. The Molecular and Genetic Basis of Neurological Diseases. 1997;581-600 Butterworth Heineman, Boston.
41. Mortimer J. A., Van Duijn C. M., Chandra L., Fratiglioni L., Graves A. B., Heyman A., Jorm A. F., Kokmen E., Kondo K., Rocca W. A., Shalat S. L., Soininen H., Hoffman A. Head trauma as a risk factor for Alzheimer's disease: A collaborative re-analysis of case-control studies. Int. J. Epidemiol. 20:1991;S28-S35.
42. Murai H., Pierce J. E. S., Raghupathi R., Smith D. H., Saatman K. E., Trojanowski J. Q., Lee V. M-Y., Loring J. F., Eckman C., Younkin S., McIntosh T. K. Two-fold over expression of human β-amyloid precursor proteins in transgenic mice does not affect the neuromotor, cognitive or neurodegenerative sequelae following experimental brain injury. J. Comp. Neurol. 392:1998;428-438.
43. Nakagawa Y., Nakamura M., McIntosh T. K., Rodriguez A., Berlin J. A., Smith D. H., Saatman K. E., Raghupathi R., Clemens J., Saido T. C., Schmidt M. L., Lee V. M-Y., Trojanowski J. Q. Traumatic brain injury in young, amyloid-beta peptide overexpressing transgenic mice induces marked ipsilateral hippocampal atrophy and diminished Aβ deposition during aging. J. Comp. Neurol. 411:1999;390-398.
44. Nakamura M., Saatman K. E., Galvin J. E., Scherbel U., Raghupathi R., Trojanowski J. Q., McIntosh T. K. Increased vulnerability of NFH-LacZ transgenic mouse to traumatic brain injury-induced behavioral deficits and cell loss. J. Cereb. Blood Flow Metab. 19:1999;762-770.
45. Namura S, Zhu J., Fink K., Endres M., Srinivasan A., Tomaselli K. J., Yuan J., Moskovitz M. A. Activation and cleavage of caspase-3 in apoptosis induced by experimental cerebral ischemia. J. Neurosci. 18:1998;3659-3668.
46. Newcomb J. K., Zhao X., Pike B. R., Hayes R. L. Temporal profile of apoptotic-like changes in neurons and astrocytes following controlled cortical impact injury in the rat. Exp. Neurol. 158:1999;76-88.
47. Nicoll J. A. R., Roberts G. W., Graham D. I. Apolipoprotein E ε4 allele is associated with deposition of amyloid β protein following head injury. Nat. Med. 1:1995;135-137.
48. Pearson B. E., Choi T. K. Expression of the human β-amyloid precursor protein gene from a yeast artificial chromosome in transgenic mice. Proc. Natl. Acad. Sci. USA. 90:1993;10,578-10,582.
49. Pierce J. E. S., Smith D. H., Trojanowski J. Q., McIntosh T. K. Enduring cognitive, neurobehavioral and histopathological changes persist for up to one year following experimental brain injury in rats. Neuroscience. 87:1998;359-369.
50. Pierce J. E. S., Trojanowski J. Q., Graham D. I., Smith D. H., McIntosh T. K. Immunohistochemical characterization of alterations in the distribution of amyloid precursor proteins and β-amyloid peptide after experimental brain injury in the rat. J. Neurosci. 16:1996;1083-1090.
51. Reaume A. G., Howland D. S., Trusko S. P., Savage M. J., Lang D. M., Greenberg B. D., Siman R., Scott R. W. Enhanced amyloidogenic processing of the β-amyloid precursor protein in gene-targeted mice bearing the Swedish familial Alzheimer's disease mutations and a humanized Aβ sequence. J. Biol. Chem. 271:1996;23,380-23,388.
52. Rink A., Fung K-M., Trojanowski J. Q., Lee V. M-Y., Neugebauer E., McIntosh T. K. Evidence of apoptotic cell death following experimental traumatic brain injury in the rat. Am. J. Pathol. 147:1995;1575-1583.
53. Roberts G. W., Allsop D., Bruton C. The occult aftermath of boxing. J. Neurol. Neurosurg. Psychiatry. 53:1990;373-378.
54. Roberts G. W., Gentleman S. M., Lynch A., Murray L., Landon M., Graham D. I. β-Amyloid protein deposition in the brain after severe head injury: Implications for the pathogenesis of Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry. 57:1994;419-425.
55. Rockenstein E. M., McConlogue L., Tan H., Powers M., Masliah E., Mucke L. Levels and alternative splicing of amyloid β protein precursor (APP) transcripts in brains of APP transgenic mice and humans with Alzheimer's disease. J. Biol. Chem. 47:1995;28,257-28,267.
56. Saido T. C. Alzheimer's disease as proteolytic disorders: Anabolism and catabolism of β-amyloid. Neurobiol. Aging. 1998;S69-S75.
57. N3(pE), in senile plaques. Neuron. 14:1995;1-20.
58. Saido T. C., Yamao-Harigaya W., Iwatsubo T., Kawashima S. Amino- and carboxyl-terminal heterogeneity of β-amyloid peptides deposited in human brain. Neurosci. Lett. 215:1996;173-176.
59. Schenk, D., R. Barbour, W. Dunn, G. Gordon, H. Grajeda, T. Guido, K. Hu, J. Huang, K. Johnson-Wood, K. Khan, D. Kholodenko, M. Lee, Z. Liao, I. Lieberburg, R. Motter, L. Mutter, F. Soriano, G. Shopp, N. Vasquiez, C. Vandevert, S. Walker, M. Wogulis, T. Yednock, D. Games, and P. Seubert. Immunization with amyloid-β attenuates Alzheimer disease-like pathology in the PDAPP mouse. Nature400:173-177.
60. Scheuner D, Eckman C., Jensen M., Song X., Citron M., Suzuki N., Bird T. D., Hardy J., Hutton M., Kukull W. A., Larson F., Levy-Lahad E., Viitanen M., Peskind E., Poorkaj P., Schellenberg G. D., Tanzi R., Wasco W., Lannfelt L., Selkoe D. J., Younkin S. Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nature Med. 2:1996;864-870.
61. Schmidt M. L., Lee V. M-Y., Saido T., Perl D., Schuck T., Iwatsubo T., Trojanowski J. Q. Amyloid plaques in Guam amyotrophic lateral sclerosis/parkinsonism-dementia complex contain species of Aβ similar to those found in the amyloid plaques of Alzheimer's disease and pathological aging. Acta Neuropathol. 95:1998;117-122.
62. Schmidt M. L., Didario A. G., Lee V. M-Y., Trojanowski J. Q. An extensive network of PHFτ-rich dystrophic neurites permeates neocortex and nearly all neuritic and diffuse amyloid plaques in Alzheimer disease. FEBS Lett. 344:1994;69-73.
63. Schofield P. W., Tang M., Marder K., Bell K., Dooneief G., Chun M., Sano M., Stern Y., Mayeux R. Alzheimer's disease after remote head injury: An incidence study. J. Neurol. Neurosurg. Psychiatry. 62:1997;119-124.
64. Selkoe D. J. Cellular and molecular biology of the beta-amyloid precursor protein and Alzheimer's disease. Prusiner S. B., Rosenberg R. N., Di Mauro S., Barchi R. L. The Molecular and Genetic Basis of Neurological Disease. 1997;601-612 Butterworth Heineman, Boston.
65. Sherriff F. E., Bridges L. R., Gentleman S. M., Sivaloganathan S., Wilson S. Markers of axonal injury in postmortem human brain. J. Neuropathol. 88:1994;433-439.
66. Shin R-W, Ogino K., Kondo A., Saido T., Trojanowski J. Q., Kitamoto T., Tateishi J. Amyloid β-protein (Aβ) 1-40 but not Aβ1-42 contributes to the experimental formation of Alzheimer's disease amyloid fibrils in rat brain. J. Neurosci. 17:1997;8187-8193.
67. Smith D. H., Chen X-H., S. J. E., Wolf J. A., Trojanowski J. Q., Graham D. I., McIntosh T. K. Progressive atrophy and neuronal cell death for one year following experimental brain trauma in the rat. J. Neurotrauma. 14:1997;715-727.
68. Smith D. H., Nakamura M., McIntosh T. K., Wang J., Rodriguez A., Raghupathi R., Saatman K. E., Clemens J., Schmidt M. L., Lee V. M-Y., Trojanowski J. Q. Brain trauma induces massive hippocampal neuron death linked to a surge in Aβ1-42 levels in mice overexpressing mutant APP. Am. J. Pathol. 153:1998;1005-1010.
69. Smith D. H., Soares H. D., Pierce J. E. S., Perlman K. G., Saatman K. E., Meaney D. F., Dixon C. E., McIntosh T. K. A model of parasagittal controlled cortical impact in the mouse: Cognitive and histopathologic effects. J. Neurotrauma. 12:1995;169-178.
70. Srinivasan A., Roth K. A., Sayers R. O., Shindler K. S., Wong A. M., Tomasellei K. J. In situ immunodetection of activated caspase-3 in apoptotic neurons in the developing nervous system. Cell Death Differ. 5:1998;1004-1016.
71. Stalder M., Phinney A., Probst A., Sommer B., Staufenbiel M., Jucker M. Association of microglia with amyloid plaques in brains of APP23 transgenic mice. Am. J. Pathol. 154:1999;1673-1684.
72. Sturchler-Pierrat C., Abramoski D., Duke M., Wiederhold K-H., Mistl C., Rothacher, Ledermann B., Buerki K., Frey P., Paganetti P. A., Waridel C., Calhoun M. E., Jucker M., Probst A., Staufenbiel M., Sommer B. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc. Natl. Acad. Sci. USA. 94:1997;13,287-13,292.
73. Su Y., Ni B. Selective deposition of amyloid-beta protein in the entorhinal-dentate projection of a transgenic mouse model of Alzheimer's disease. J. Neurosci. Res. 53:1998;177-186.
74. 717) mutants. Science. 264:1994;1336-1340.
75. Teasdale G. M., Nicoll J. A. R., Murray G., Fiddes M. Association of apolipoprotein E polymorphism with outcome after head injury. Lancet. 350:1997;1069-1071.
76. Tokuda T., Ikeda S., Yanagisawa N., Ihara Y., Glenner G. G. Re-examination of ex-boxers' brains using immunohistochemistry with antibodies to amyloid β-protein and tau protein. Acta Neuropathol. 82:1991;281-285.